Home
关于我们
产品中心
新闻资讯
技术文章
定制合成
联系我们
中文
产品中心
PRODUCTS
Current location:
Home
>>
产品中心
>>
抗体
PRODUCT CLASSIFICATION
News
NEWS
Application of bioactive small molecules in disease research
Green intelligence creates industry trends, Fuzhen Biology promotes low-carbon development of fine chemical industry
The monoclonal antibody industry is developing rapidly, and Fuzhen Biotechnology is improving its supply system for monoclonal antibody related raw materials
The global biopharmaceutical market continues to expand
Molecular building blocks are used as accelerators for the development of new drugs
Structural formula
Art.No.
Name
CAS
Pureness
CFZ02204
Tuvirumab
138660-97-6
95%
CFZ02203
Keliximab
174722-30-6
95%
CFZ02202
Infliximab
170277-31-3
95%
CFZ02189
Cetuximab
205923-56-4
95%
CFZ02188
Bavituximab
648904-28-3
95%
CFZ02187
Modotuximab
1310460-86-6
95%
CFZ02186
Perakizumab
1331830-76-2
95%
CFZ02185
Solitomab
1005198-65-1
95%
CFZ02184
Dusigitumab
1204390-13-5
95%
CFZ02183
Vorsetuzumab
1165740-62-4
95%
Home
<<
···
41
42
43
44
45
···
43/59
>>
Last
QQ
QQ
Service Hotline:
15111215862
18229892877